We examined whether
prostaglandin (PG) H2, as an endothelium-dependent contracting factor, or the disturbed production of
endothelium-derived relaxing factor, impairs endothelium-dependent relaxation and whether long-term inhibition of
nitric oxide (NO) synthesis aggravates
atherosclerosis in hypercholesterolemic rabbits. Male New Zealand White rabbits were fed one of the following diets: (1) standard chow; (2) 2%
cholesterol-supplemented chow; (3) standard chow with 80 micrograms/mL
N omega-nitro-L-arginine methylester (
L-NAME), an NO
synthetase inhibitor, in their
drinking water; or (4) 2%
cholesterol-supplemented chow with 80 or 160 micrograms/mL
L-NAME in their
drinking water. The rabbits were fed these diets for 8 or 12 weeks. Then aortic rings were obtained, and changes in isometric tension were recorded. Intimal atherosclerotic areas of the thoracic aortas were subsequently measured by planimetry. The
cholesterol-supplemented diet significantly impaired endothelium-dependent aortic relaxation to
acetylcholine. Pretreatment with the
thromboxane A2/
PGH2 receptor antagonist
ONO-3708 did not reverse this impaired response. Vessels from both normocholesterolemic and hypercholesterolemic rabbits given
L-NAME showed more impaired endothelium-dependent relaxation than those from their dietary counterparts not given
L-NAME. Morphometric analysis revealed marked enlargement of intimal atherosclerotic areas in aortas from
L-NAME-treated hypercholesterolemic rabbits compared with those from untreated hypercholesterolemic rabbits. These findings suggest that
PGH2 does not contribute to impaired endothelium-dependent relaxation and that long-term administration of
L-NAME promotes
atherosclerosis by inhibition of NO synthesis in the hypercholesterolemic rabbit thoracic aorta.